Valneva SE logo

Valneva SE

EPA:VLA.PA

Overview | Financials
Company Name Valneva SE
Symbol VLA.PA
Currency EUR
Price 2.652
Market Cap 430,028,902
Dividend Yield 0%
52-week-range 2.466 - 7.168
Industry Biotechnology
Sector Healthcare
CEO Mr. Thomas Lingelbach
Website https://valneva.com

An error occurred while fetching data.

About Valneva SE

Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention

Related Stocks

Fagron NV logo

Fagron NV

FAGR.BR

18.58 EUR

Faes Farma, S.A. logo

Faes Farma, S.A.

FAE.MC

3.58 EUR

Arvida Group Limited logo

Arvida Group Limited

ARV.NZ

1.21 NZD

Riverstone Holdings Limited logo

Riverstone Holdings Limited

AP4.SI

0.905 SGD

Pharma Mar, S.A. logo

Pharma Mar, S.A.

PHM.MC

73.9 EUR

Uniphar plc logo

Uniphar plc

UPR.IR

2.2 EUR

Vetoquinol SA logo

Vetoquinol SA

VETO.PA

79.4 EUR

Orpea SA logo

Orpea SA

ORP.PA

12.312 EUR

Boiron SA logo

Boiron SA

BOI.PA

32.6 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD